|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: INVESCO COMBINATION STOCK & BOND FUNDS INC, 497, 2000-07-21 |
Next: BOSTON CAPITAL TAX CREDIT FUND IV LP, S-11/A, 2000-07-21 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 21, 2000
SANGSTAT MEDICAL CORPORATION (Exact name of registrant as specified in its charter)
|
|
|
|
|
|
6300 Dumbarton Circle
Fremont, California 94555
(Address of principal executive offices including zip code)
510-789-4300
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Item 5. Other Matters
Dr. Elliott B. Grossbard, M.D., Senior Vice President of Medical Development resigned effective July 21, 2000. Dr. Raymond J. Tesi, M.D., Senior Vice President, Medical Affairs and Strategic Development, will be managing Clinical Development until a replacement for Dr. Grossbard is hired. Regulatory and Compliance will report directly into Jean-Jacques Bienaimé, President and CEO.
Item 7. Financial Statements and Exhibits
(a) Financial statements of business acquired. - Not applicable
(b) Pro forma financial information. - Not applicable
(c) Exhibits. - None
SIGNATURES
Pursuant to the requirement of the Security Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: July 21, 2000
| SANGSTAT MEDICAL CORPORATION |
| By: | /s/ Stephen G. Dance |
|
| |
| Stephen G. Dance | |
| Senior Vice President, Finance |
|
|